載入...

Real‐world efficacy and potential mechanism of resistance of icotinib in Asian advanced non‐small cell lung cancer with EGFR uncommon mutations: A multi‐center study

The response to icotinib in advanced non‐small cell lung cancers (NSCLC) with EGFR uncommon mutation (EGFRum) is unclear. Here we reported the efficacy and potential resistance mechanism of icotinib in Chinese EGFRum NSCLC patients. Between July 2013 and November 2016, 3117 NSCLC patients were scree...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cancer Med
Main Authors: Lei, Lei, Wang, Wen‐xian, Zhu, You‐cai, Li, Jin‐luan, Fang, Yong, Wang, Hong, Zhuang, Wu, Zhang, Yin‐bin, Wang, Li‐ping, Fang, Mei‐yu, Xu, Chun‐wei, Wang, Xiao‐jia, Lv, Tang‐feng, Song, Yong
格式: Artigo
語言:Inglês
出版: John Wiley and Sons Inc. 2019
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6943154/
https://ncbi.nlm.nih.gov/pubmed/31692291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2652
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!